CrushSCI.com
提供学术论文选刊润色服务
INTERNATIONAL JOURNAL OF HEMATOLOGY 期刊封面 医学
返回期刊列表

Review Cycle Records

INTERNATIONAL JOURNAL OF HEMATOLOGY

Springer SCIE 非OA
2026新锐 4区2025中科院 4区2025 JCR Q3
92.8平均天数
70.5中位天数
16最短天数
205最长天数
2372025发文量

Paper Review Records

全部论文审稿周期

12 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

70 天

Late acquisition of BCR::ABL1 during clonal evolution of SAMD9- associated MDS with phenotypic shift from AML to B-ALL

作者Yusuke Nakata; Anna Hiratsuka; Takeshi Yoroidaka; Wakana Takahashi; Itaru Nishikawa; Masataka Sakashita; Shinya Yamada; Hiroki Mizumaki; Akiyo Yoshida; Tatsuya Imi; Hiroyuki Maruyama; Hiroyuki Takamatsu; Kohei Hosokawa; Yasuhito Nannya; Seishi Ogawa; Toshihiro Miyamoto

作者单位1. Department of Hematology, Faculty of Medicine, Institute of Medical Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan; 2. Division of Hematology, Keiju Kanazawa Hospital, Kanazawa, Japan; 3. Division of Hematopoietic Disease Control, Institute of Medical Science, The University of Tokyo, Tokyo, Japan; 4. Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan

PDF源文件 DOI 网页
119 天

Improved post-transplant outcomes following inotuzumab ozogamicin-based salvage therapy in relapsed/refractory B-ALL: a real-world retrospective study

作者Ryo Koizumi; Shinsuke Takagi; Aya Nishida; Mika Kuno; Rikako Tabata; Otoya Watanabe; Kyosuke Yamaguchi; Kosei Kageyama; Daisuke Kaji; Yuki Taya; Kazuya Ishiwata; Hisashi Yamamoto; Akiko Masuda; Yukako Koike; Hideki Araoka; Yuki Asano-Mori; Go Yamamoto; Atsushi Wake; Shuichi Taniguchi; Naoyuki Uchida

作者单位1. Department of Hematology, Toranomon Hospital, Tokyo, Japan; 2. Center for Long-Term Follow-Up After Hematopoietic Cell Transplantation, Toranomon Hospital, Tokyo, Japan; 3. Okinaka Memorial Institute for Medical Research, Tokyo, Japan; 4. Department of Hematology, Toranomon Hospital Kajigaya, Kawasaki, Japan; 5. Department of Transfusion and Cellular Therapy, Toranomon Hospital, Tokyo, Japan; 6. Center for Cellular Therapy, Toranomon Hospital, Tokyo, Japan; 7. Department of Clinical Laboratory, Toranomon Hospital, Tokyo, Japan

PDF源文件 DOI 网页
113 天

Gene editing of hematopoietic stem cells: applications and advances

作者Qiuyang Li; Hongxia Wang; Yuqin He; Genyue Hong; Guoxiu Bao

作者单位1. Department of Hematology, Dali Bai Autonomous Prefecture People’s Hospital in Dali, Dali City, China

PDF源文件 DOI 网页
68 天

Long-term treatment-free remission in CML after early dasatinib discontinuation due to interstitial pneumonitis

作者Makoto Kashimura; Yuki Fujioka; Yong-Mei Guo; Teruko Takahashi; Keiichi Moriya; Naoto Takahashi

作者单位1. Division of Hematology, Shinmatsudo Central General Hospital, Matsudo, Japan; 2. Division of Central Laboratory, Akita University Hospital, Akita, Japan; 3. Department of Hematology, Nephrology and Rheumatology, Akita University Graduate School of Medicine, Akita, Japan

PDF源文件 DOI 网页
205 天

Efficacy and safety of maribavir in Japanese patients with post-transplant cytomegalovirus infections: a phase III study

作者Yoshinobu Kanda; Katsuto Takenaka; Tatsu Tanabe; Kazuya Omoto; Kei Kamimura; Kentaro Kudou; Masato Kaneko

作者单位1. Division of Hematology, Jichi Medical University, Shimotsuke, Japan; 2. Department of Hematology, Clinical Immunology and Infectious Diseases, Ehime University, Matsuyama, Japan; 3. Department of Kidney Transplant Surgery, Sapporo City General Hospital, Sapporo, Japan; 4. Yochomachi Clinic, Tokyo, Japan; 5. Takeda Pharmaceutical Company Limited, Osaka, Japan

PDF源文件 DOI 网页
71 天

TFH phenotype and response to tucidinostat in relapsed/refractory PTCL: analysis of patients from a phase IIb trial

作者Koji Izutsu; Ayumi Fujimoto; Shinya Rai; Dai Maruyama; Ken Ohmachi; Akihiko Yokohama; Kunihiro Tsukasaki; Toshiki Uchida; Junya Kuroda; Ilseung Choi; Michihiro Hidaka; Jun Ando; Takashi Sakamoto; Hisashi Kato; Hironobu Minami; Shinichiro Yoshida; Matsuo Yamamoto; Mireille Gillings; Hiroshi Onogi; Kengo Takeuchi

作者单位1. Department of Hematology, National Cancer Center Hospital, Tokyo, Japan; 2. Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan; 3. Pathology Project for Molecular Targets, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan; 4. Department of Hematology and Rheumatology, Faculty of Medicine, Kindai University, Sakai, Japan; 5. Department of Hematology Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan; 6. Department of Hematology and Oncology, Tokai University Hospital, Isehara, Japan; 7. Department of Hematology, Gunma University Hospital, Maebashi, Japan; 8. Department of Hematology, International Medical Center, Saitama Medical University, Hidaka, Japan; 9. Department of Hematology and Oncology, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan; 10. Division of Hematology and Oncology, Kyoto Prefectural University of Medicine, Kyoto, Japan; 11. Department of Hematology and Cell Therapy, NHO Kyushu Cancer Center, Fukuoka, Japan; 12. Department of Hematology, NHO Kumamoto Medical Center, Kumamoto, Japan; 13. Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan; 14. Department of Hematology, Graduate School of Medicine, Kyoto University, Kyoto, Japan; 15. Department of Hematology and Oncology, The University of Osaka Graduate School of Medicine, Suita, Japan; 16. Division of Medical Oncology and Hematology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan; 17. Department of Hematology, NHO Nagasaki Medical Center, Omura, Japan; 18. Clinical Research Center, NHO Nagoya Medical Center, Nagoya, Japan; 19. HUYA BIO International, LLC, San Diego, USA; 20. Huya Japan GK, Tokyo, Japan

PDF源文件 DOI 网页
98 天

NPM1-rearranged AML: clinical features, molecular pathogenesis, and therapeutic perspectives

作者Yuko Shimosato; Susumu Goyama

作者单位1. Division of Molecular Oncology, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Minato-ku, Japan

PDF源文件 DOI 网页
65 天

Role of cross-mixing tests in differentiating etiologies of prolonged aPTT: a single-center retrospective study

作者Nahomi Suita; Aozora Kanemaru; Noriko Komori; Koichi Nitta; Haruyuki Fujita; Hiroshi Kawabata

作者单位1. Department of Clinical Laboratory, NHO Kyoto Medical Center, Kyoto, Japan; 2. Department of Hematology, NHO Kyoto Medical Center, Kyoto, Japan

PDF源文件 DOI 网页
165 天

Clinical implications of minimal residual disease monitoring in multiple myeloma

作者Takeshi Yoroidaka

作者单位1. Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, Kanazawa, Japan

PDF源文件 DOI 网页
62 天

Effectiveness and tolerability of switching from 20% subcutaneous immunoglobulin to hyaluronidase-facilitated subcutaneous immunoglobulin 10% in the same patients with secondary hypogammaglobulinemia

作者Yoshinori Hashimoto; Saaya Hosoda; Hiromi Omura; Takayuki Tanaka

作者单位1. Department of Hematology, Tottori Prefectural Central Hospital, Tottori, Japan

PDF源文件 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿96.4 天

中位数77 天

Contact CrushSCI

联系 CrushSCI

扫码添加微信,或留下手机号/微信号,我们将与你确认稿件阶段、编辑需求和投稿计划。

当前选择:论文编辑服务

也可以预留联系方式

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。